You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

icp-022

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Systemic Lupus Erythematosus Trial in China (ICP-022, Placebos)

Completed
  • Systemic Lupus Erythematosus
  • ICP-022
  • Placebos
  • Bengbu, Anhui, China
  • +10 more
Nov 28, 2022

CLL/SLL Trial in China (ICP-022)

Active, not recruiting
  • CLL/SLL
  • ICP-022
  • Hefei, Anhui, China
  • +24 more
Jul 5, 2022

PCNSL, Secondary CNS Lymphoma Trial in Beijing, Guangzhou, Shanghai (ICP-022)

Recruiting
  • PCNSL
  • Secondary Central Nervous System Lymphoma
  • ICP-022
  • Beijing, Beijing, China
  • +4 more
Jul 28, 2021

Mantle Cell Lymphoma Trial in China (ICP-022)

Active, not recruiting
  • Mantle Cell Lymphoma
  • ICP-022
  • Hefei, Anhui, China
  • +30 more
Jul 5, 2022

Diffuse Large B Cell Lymphoma Trial in China (ICP-022)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • ICP-022
  • Haerbin, Heilongjiang, China
  • +5 more
Jul 28, 2021

CNS Lymphoma Trial in Zhengzhou (ICP-022, Pemetrexed)

Recruiting
  • Central Nervous System Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jan 28, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in China (ICP-022, Chlorambucil, Rituximab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • ICP-022
  • +2 more
  • Bengbu, Anhui, China
  • +55 more
Mar 25, 2022

Systemic Lupus Erythematosus, Rheumatoid Arthritis Trial in Adelaide (ICP-022, Placebos)

Completed
  • Systemic Lupus Erythematosus
  • Rheumatoid Arthritis
  • ICP-022
  • Placebos
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Jul 30, 2019